- Corporate Officers - H
- Hoffman Robert E.
Insider Trading History of Hoffman Robert E.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hoffman Robert E. since 2006.
This trader's CIK number is 1166288.
At the time of last reporting, Hoffman Robert E. was the President and CEO of Kintara Therapeutics, Inc.. (stock ticker symbol KTRA).
Also see all insider trading activities at Kintara Therapeutics, Inc..
Note that in the past
Hoffman Robert E. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Arena Pharmaceuticals Inc (ARNA) by Hoffman Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ARNA | 0 | $0 | 71,250 | $585,105 | 71,250 | $128,962 |
| 2012 | ARNA | 0 | $0 | 60,000 | $526,000 | 50,000 | $74,000 |
| 2008 | ARNA | 0 | $0 | 10,000 | $61,640 | 0 | $0 |
| 2006 | ARNA | 0 | $0 | 7,500 | $78,637 | 5,000 | $3,000 |
Yearly summary of insider trading at Mabvax Therapeutics Holdings, Inc. (MBVX) by Hoffman Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | MBVX | 0 | $0 | 0 | $0 | 1,543 | $0 |
| 2016 | MBVX | 0 | $0 | 0 | $0 | 11,417 | $0 |
| 2014 | MBVX | 10,000 | $24,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kintara Therapeutics, Inc. (KTRA) by Hoffman Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | KTRA | 55,000 | $25,795 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Combimatrix Corp (CBMX) by Hoffman Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | CBMX | 5,000 | $15,965 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Hoffman Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | HRTX | 0 | $0 | 30,000 | $1,154,190 | 30,000 | $459,000 |
Insider trading activities at 5 companies by Hoffman Robert E.:
1. Arena Pharmaceuticals Inc (ARNA)
2. Mabvax Therapeutics Holdings, Inc. (MBVX)
3. Kintara Therapeutics, Inc. (KTRA)
4. Combimatrix Corp (CBMX)
5. Heron Therapeutics, Inc. /de/ (HRTX)
Table 1. Insider trading of Arena Pharmaceuticals Inc (ARNA) by Hoffman Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-04-01 | ARNA | Option Ex | 71,250 | 1.81 | 128,962 |
| 2013-04-01 | ARNA | Sale | 71,250 | 8.21 | 585,105 |
| 2012-10-01 | ARNA | Option Ex | 50,000 | 1.48 | 74,000 |
| 2012-10-01 | ARNA | Sale | 50,000 | 8.32 | 416,000 |
| 2012-07-05 | ARNA | Sale | 10,000 | 11.00 | 110,000 |
| 2008-09-02 | ARNA | Sale | 10,000 | 6.16 | 61,640 |
| 2006-07-31 | ARNA | Option Ex | 5,000 | .60 | 3,000 |
| 2006-07-31 | ARNA | Sale | 7,500 | 10.48 | 78,637 |
Table 2. Insider trading of Mabvax Therapeutics Holdings, Inc. (MBVX) by Hoffman Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-04-02 | MBVX | Option Ex | 1,543 | .00 | 0 |
| 2016-04-04 | MBVX | Option Ex | 11,417 | .00 | 0 |
| 2014-12-16 | MBVX | Buy | 10,000 | 2.40 | 24,000 |
Table 3. Insider trading of Kintara Therapeutics, Inc. (KTRA) by Hoffman Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-02-15 | KTRA | Buy | 55,000 | .47 | 25,795 |
Table 4. Insider trading of Combimatrix Corp (CBMX) by Hoffman Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-05-10 | CBMX | Buy | 5,000 | 3.19 | 15,965 |
Table 5. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Hoffman Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-07-02 | HRTX | Option Ex | 30,000 | 15.30 | 459,000 |
| 2018-07-02 | HRTX | Sale | 30,000 | 38.47 | 1,154,190 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hoffman Robert E.
(President and CEO of Kintara Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.